Comparative effectiveness of HMA with venetoclax vs intensive chemotherapy in AML with very high-risk cytogenetics

Blood Neoplasia 2026 Open access

Read full text
Authors: Luis E. Aguirre, Jan Philipp Bewersdorf, Y. Liu, Rory M. Shallis, Leora Boussi, Andrius Žučenka, Sylvain Garciaz, Rebecca P. Bystrom, Daniel J. DeAngelo, Richard M. Stone, Marlise R. Luskin, Jacqueline S. Garcia
+12 more Eric S. Winer, Kelly Ling, Evan C. Chen, Martha Wadleigh, Guillaume Berton, Eytan M. Stein, Aaron D. Goldberg, Lourdes Mendez, Amer M. Zeidan, David A. Sallman, Shai Shimony, Maximilian Stahl
DOI: 10.1016/j.bneo.2026.100201
Cited by: 4
References: 23

Fields of Study & Subjects

Acute Myeloid Leukemia Research Retinoids in leukemia and cellular processes Myeloproliferative Neoplasms: Diagnosis and Treatment

Publication details

Journal / source
Blood Neoplasia
Publisher
Elsevier BV
Volume
3
Issue
2
Pages
100201–100201
Publication date
28 January 2026
Language
EN